The Impact of COVID-19 is included in Chronic Kidney Disease Market Report. Buy it today to get an advantage.
Request the impact of COVID-19 on your product or industry
Chronic Kidney Disease Trends and Forecast
The future of the global chronic kidney disease market looks promising with opportunities in the hospital and dialysis center markets. The global chronic kidney disease market is expected to reach an estimated $83.6 billion by 2030 with a CAGR of 6.5% from 2024 to 2030. The major drivers for this market are rising occurence of CKD and usage of technologically advanced products and diagnostics tests.
A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.
Chronic Kidney Disease by Segment
The study includes a forecast for the global chronic kidney disease by treatment, end use, and region.
Chronic Kidney Disease Market by Treatment [Shipment Analysis by Value from 2018 to 2030]:
• Drugs
• Dialysis
Chronic Kidney Disease Market by End Use [Shipment Analysis by Value from 2018 to 2030]:
• Hospital
• Dialysis Center
• Others
Chronic Kidney Disease Market by Region [Shipment Analysis by Value from 2018 to 2030]:
• North America
• Europe
• Asia Pacific
• The Rest of the World
List of Chronic Kidney Disease Companies
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies chronic kidney disease companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the chronic kidney disease companies profiled in this report include-
• Baxter International
• Teva Pharmaceutical Industries
• AstraZeneca
• Johnson & Johnson
• AbbVie
• Becton
• Dickinson and Company
• B. Braun
• F. Hoffmann-La Roche
• Pfizer
Chronic Kidney Disease Market Insights
Lucintel forecasts that drugs are expected to witness the higher growth over the forecast period due to introduction of new drugs and therapies to help healthcare professional to treat patients effectively.
Within this market, hospitals is expected to witness the higher growth as it is equipped with advanced facilities, which are required to treat and manage CKD
APAC is expected to witness highest growth over the forecast period due to the presence of substantial number of patients and increasing demand of quality healthcare in the region.
Features of the Global Chronic Kidney Disease Market
Market Size Estimates: Chronic kidney disease market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
Segmentation Analysis: Chronic kidney disease market size by treatment, end use, and region in terms of value ($B).
Regional Analysis: Chronic kidney disease market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different treatments, end uses, and regions for the chronic kidney disease market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the chronic kidney disease market.
Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
FAQ
Q1. What is the chronic kidney disease market size?
Answer: The global chronic kidney disease market is expected to reach an estimated $83.6 billion by 2030.
Q2. What is the growth forecast for chronic kidney disease market?
Answer: The global chronic kidney disease market is expected to grow with a CAGR of 6.5% from 2024 to 2030.
Q3. What are the major drivers influencing the growth of the chronic kidney disease market?
Answer: The major drivers for this market are rising occurence of CKD and usage of technologically advanced products and diagnostics tests.
Q4. What are the major segments for chronic kidney disease market?
Answer: The future of the chronic kidney disease market looks promising with opportunities in the hospital and dialysis center markets.
Q5. Who are the key chronic kidney disease market companies?
Answer: Some of the key chronic kidney disease companies are as follows:
• Baxter International
• Teva Pharmaceutical Industries
• AstraZeneca
• Johnson & Johnson
• AbbVie
• Becton
• Dickinson and Company
• B. Braun
• F. Hoffmann-La Roche
• Pfizer
Q6. Which chronic kidney disease market segment will be the largest in future?
Answer: Lucintel forecasts that drugs are expected to witness the higher growth over the forecast period due to introduction of new drugs and therapies to help healthcare professional to treat patients effectively.
Q7. In chronic kidney disease market, which region is expected to be the largest in next 5 years?
Answer: APAC is expected to witness highest growth over the forecast period due to the presence of substantial number of patients and increasing demand of quality healthcare in the region.
Q.8 Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% customization without any additional cost.
This report answers following 11 key questions:
Q.1. What are some of the most promising, high-growth opportunities for the chronic kidney disease market by treatment (drugs and dialysis), end use (hospital, dialysis center, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?
For any questions related to Chronic Kidney Disease Market, Chronic Kidney Disease Market Size, Chronic Kidney Disease Market Growth, Chronic Kidney Disease Market Analysis, Chronic Kidney Disease Market Report, Chronic Kidney Disease Market Share, Chronic Kidney Disease Market Trends, Chronic Kidney Disease Market Forecast, Chronic Kidney Disease Companies, write Lucintel analyst at email: helpdesk@lucintel.com. We will be glad to get back to you soon.
Table of Contents
1. Executive Summary
2. Global Chronic Kidney Disease Market : Market Dynamics
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. Market Trends and Forecast Analysis from 2018 to 2030
3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
3.2. Global Chronic Kidney Disease Market Trends (2018-2023) and Forecast (2024-2030)
3.3: Global Chronic Kidney Disease Market by Treatment
3.3.1: Drugs
3.3.2: Dialysis
3.4: Global Chronic Kidney Disease Market by End Use
3.4.1: Hospital
3.4.2: Dialysis Center
3.4.3: Others
4. Market Trends and Forecast Analysis by Region from 2018 to 2030
4.1: Global Chronic Kidney Disease Market by Region
4.2: North American Chronic Kidney Disease Market
4.2.2: North American Chronic Kidney Disease Market by End Use: Hospital, Dialysis Center, and Others
4.3: European Chronic Kidney Disease Market
4.3.1: European Chronic Kidney Disease Market by Treatment: Drugs and Dialysis
4.3.2: European Chronic Kidney Disease Market by End Use: Hospital, Dialysis Center, and Others
4.4: APAC Chronic Kidney Disease Market
4.4.1: APAC Chronic Kidney Disease Market by Treatment: Drugs and Dialysis
4.4.2: APAC Chronic Kidney Disease Market by End Use: Hospital, Dialysis Center, and Others
4.5: ROW Chronic Kidney Disease Market
4.5.1: ROW Chronic Kidney Disease Market by Treatment: Drugs and Dialysis
4.5.2: ROW Chronic Kidney Disease Market by End Use: Hospital, Dialysis Center, and Others
5. Competitor Analysis
5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter’s Five Forces Analysis
6. Growth Opportunities and Strategic Analysis
6.1: Growth Opportunity Analysis
6.1.1: Growth Opportunities for the Global Chronic Kidney Disease Market by Treatment
6.1.2: Growth Opportunities for the Global Chronic Kidney Disease Market by End Use
6.1.3: Growth Opportunities for the Global Chronic Kidney Disease Market by Region
6.2: Emerging Trends in the Global Chronic Kidney Disease Market
6.3: Strategic Analysis
6.3.1: New Product Development
6.3.2: Capacity Expansion of the Global Chronic Kidney Disease Market
6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Chronic Kidney Disease Market
6.3.4: Certification and Licensing
7. Company Profiles of Leading Players
7.1: Baxter International
7.2: Teva Pharmaceutical Industries
7.3: AstraZeneca
7.4: Johnson & Johnson
7.5: AbbVie
7.6: Becton
7.7: Dickinson and Company
7.8: B. Braun
7.9: F. Hoffmann-La Roche
7.10: Pfizer
.
Buy full report or by chapter as follows
Lucintel has been in the business of market research and management consulting since 2000 and has published over 1000 market intelligence reports in various markets / applications and served over 1,000 clients worldwide. This study is a culmination of four months of full-time effort performed by Lucintel's analyst team. The analysts used the following sources for the creation and completion of this valuable report:
In-depth interviews of the major players in this market
Detailed secondary research from competitors’ financial statements and published data
Extensive searches of published works, market, and database information pertaining to industry news, company press releases, and customer intentions
A compilation of the experiences, judgments, and insights of Lucintel’s professionals, who have analyzed and tracked this market over the years.
Extensive research and interviews are conducted across the supply chain of this market to estimate market share, market size, trends, drivers, challenges, and forecasts. Below is a brief summary of the primary interviews that were conducted by job function for this report.
Thus, Lucintel compiles vast amounts of data from numerous sources, validates the integrity of that data, and performs a comprehensive analysis. Lucintel then organizes the data, its findings, and insights into a concise report designed to support the strategic decision-making process. The figure below is a graphical representation of Lucintel’s research process.
Please sign in below to get report brochure - Chronic Kidney Disease Market Report.